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Abstract View  
NEUROPEPTIDE Y AND ITS RECEPTOR ANALOGS MODULATE ISCHEMIA-
INDUCED NITRIC OXIDE PRODUCTION.  
S.H. Chen*; R.T.F. Cheung  
Dept Med, Queen Mary Hosp Univ Hong Kong, hong kong, Hong Kong 
We previously showed that intracerebroventricular (ICV) injection of neuropeptide Y (NPY) or 
Y1 agonist increased the infarct volume whereas administration of BIBP3226, a NPY Y1 
antagonist, reduced the infarct volume. Nitric oxide (NO) is a mediator of ischemic damage. In 
this study, we examined the effects of NPY and its receptor analogs on NO production during 
middle cerebral artery occlusion. Male Sprague-Dawley rats were anesthetized with sodium 
pentobarbital. NPY (10 mcg/kg), [Leu31, Pro34]-NPY (30 mcg/kg), BIBP3226 (15 mcg/kg), 
NPY3-36 (15 mcg/kg) or vehicle was administered via a slow ICV injection at 2 minutes after 
onset of ischemia. NO measurement was made in the brain slices between Bregma levels +2 
and 4 mm. NO trapping reagents, diethyldithiocarbamate and iron citrate, were administered 
via intraperitoneal and subcutaneous injection, respectively, at 15 minutes prior to ischemia. 
Tissue NO concentration was measured using electron paramagnetic resonance spectroscopy. 
Results from the ischemic side were expressed as a percentage of the non-ischemic side and 
compared among groups using two-tailed Student s t test. After 15 minutes of focal cerebral 
ischemia, the relative NO concentration increased to 131.9 8.0% (mean SEM; n=8). NPY 
treatment further increased the NO signal (250.9 50.5%; n=8, P<0.05), whereas BIBP3226 
reduced the NO signal (69.6 8.8%; n=8, P<0.05). Treatment with [Leu31, Pro34]-NPY and 
NPY3-36 did not affect the ischemia-induced NO signal (133.4 13.3%, n=8; 129.2 21.8%, 
n=8). Thus, exogenous NPY and its receptor analogs may affect the infarct volume via their 
effects on ischemic-induced NO generation.  
 
